§ 27-18-82. Opioid antagonists.
(a) Every individual or group health insurance contract, plan, or policy that provides
prescription coverage that is delivered, issued for delivery, amended, or renewed
in this state on or after January 1, 2017, shall provide coverage for at least one
generic opioid antagonist and device. Prior authorization may be required for non-generic
forms of opioid antagonists and devices.
(b) As used in this section:
"Opioid antagonist� means naloxone hydrochloride and any other drug approved by the
United States Food and Drug Administration
Free access — add to your briefcase to read the full text and ask questions with AI
§ 27-18-82. Opioid antagonists.
(a) Every individual or group health insurance contract, plan, or policy that provides
prescription coverage that is delivered, issued for delivery, amended, or renewed
in this state on or after January 1, 2017, shall provide coverage for at least one
generic opioid antagonist and device. Prior authorization may be required for non-generic
forms of opioid antagonists and devices.
(b) As used in this section:
"Opioid antagonist� means naloxone hydrochloride and any other drug approved by the
United States Food and Drug Administration for the treatment of opioid overdose.
(c) The coverage mandated by this section shall include generic opioid antagonists prescribed
or dispensed via standing order or collaborative practice agreement intended for use
on patients other than the insured. Prior authorization may be required for non-generic
forms of opioid antagonists and devices.
(d) Notwithstanding §â€‚27-18-19, or any other provision to the contrary, this section shall apply to blanket or group
policies of insurance.